MEDENTUM
LIVE

Serial Number

90823761

Owner

Medentum Innovations

Attorney

Jesse A. Salen

First Use Date

Jun 3, 2024

Filing Date

Jul 12, 2021

Add to watchlist:

No watchlists yet
View on USPTO

MEDENTUM Trademark

Serial Number: 90823761 • Registration: 8145616

MEDENTUM is a trademark filed by Medentum Innovations on July 12, 2021. The trademark is classified under Class 9 (Computers & Electronics). The application is currently registered and active.

Owner Contact Info

Medentum Innovations (5 trademarks)

818 Happy Valley Drive, Suite 338
Clintwood, VA 24228

Entity Type: 03

Trademark Details

Filing Date

July 12, 2021

Registration Date

February 17, 2026

First Use Anywhere

June 3, 2024

First Use in Commerce

June 15, 2024

Published for Opposition

October 17, 2023

Goods & Services

Software as a Medical Device (SaMD), downloadable, for analyzing heart rate data; Software as a Medical Device (SaMD), downloadable and recorded, for diagnosing managing and treating ear, nose and throat conditions such as ear infection, strep throat and allergies; Software as a Medical Device (SaMD), downloadable and recorded, for diagnosing and treating cardiac conditions such as high blood pressure, heart arrhythmia and CHF, endocrine conditions such as diabetes and thyroid conditions, infections such as viral infections and pneumonia, neurological conditions such as migraines and neuropathy conditions, respiratory conditions such as asthma and COPD conditions, gastroenterology conditions such as IBD, IBS, and GERD conditions, skin conditions such as eczema and moles; Software as a Medical Device (SaMD), downloadable, for measuring and displaying the electrical signal produced by the heart; Software as a Medical Device (SaMD), downloadable, for the treatment of diabetes by monitoring glucose levels; Software as a Medical Device (SaMD), downloadable, for tracking physical changes of skin moles to determine the risk of melanoma; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating ear, nose and throat conditions such as ear infection, strep throat and allergies; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating cardiac conditions such as high blood pressure, heart arrhythmia and CHF; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating endocrine conditions such as diabetes and thyroid conditions; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating infections such as viral infection and pneumonia; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating neurological conditions such as migraines and neuropathy conditions; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating respiratory conditions such as asthma and COPD conditions; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating gastroenterology conditions such as IBD, IBS and GERD conditions; Software as a Medical Device (SaMD), downloadable and recorded, for use as a medical instrument for treating skin conditions such as eczema and moles; Software as a Medical Device (SaMD), downloadable, for use as electrocardiographs; Computer hardware and recorded software sold as a unit for use with medical patient monitoring equipment, for receiving, processing, transmitting and displaying data; Downloadable Software as a Medical Device (SaMD) for remote monitoring of labor progress by processing uterine contraction and fetal heart rate data during labor and child birth ; Downloadable chatbot software using artificial intelligence for making medical diagnosis and treatment predictions using machine-learning algorithms and clinical data collected from medical instrument with integrated sensors and component software; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating ear, nose and throat conditions such as ear infection, strep throat and allergies on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating cardiac conditions such as high blood pressure, heart arrhythmia and CHF on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating endocrine conditions such as diabetes and thyroid conditions on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating infections such as viral infection and pneumonia on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating neurological conditions such as migraines and neuropathy conditions on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating respiratory conditions such as asthma and COPD conditions on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating gastroenterology conditions such as IBD, IBS and GERD conditions on a blockchain; Downloadable computer software for accessing, reading, and tracking information in the field of diagnosing and treating skin conditions such as eczema and moles on a blockchain; Downloadable computer software for controlling and managing patient medical information; Recorded computer software using artificial intelligence for making medical diagnosis and treatment predictions using machine-learning algorithms and clinical data collected from medical instrument with integrated sensors and component software

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 17, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 17, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jan 29, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jan 29, 2026 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 31, 2025 TEME
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jul 31, 2025 CHAN
ASSIGNED TO LIE
Jul 31, 2025 ALIE
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 22, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 22, 2025 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Apr 4, 2025 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Apr 4, 2025 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 25, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 25, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 25, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 6, 2024 SUPC
USE AMENDMENT FILED
Dec 4, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Dec 4, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jul 18, 2024 EXRA
SOU EXTENSION 1 GRANTED
Jul 18, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jul 18, 2024 AITU
SOU EXTENSION 1 FILED
Jun 9, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 9, 2024 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 29, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 29, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 29, 2023 REAP
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 12, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 17, 2023 NPUB
PUBLISHED FOR OPPOSITION
Oct 17, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 27, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 8, 2023 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 8, 2023 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 8, 2023 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 8, 2023 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 19, 2023 GNRN
NON-FINAL ACTION E-MAILED
Jun 19, 2023 GNRT
NON-FINAL ACTION WRITTEN
Jun 19, 2023 CNRT
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Jan 27, 2023 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Nov 15, 2022 PBCR
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 2, 2022 CNSA
EXAMINER'S AMENDMENT ENTERED
Nov 2, 2022 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Nov 2, 2022 GNEN
EXAMINERS AMENDMENT E-MAILED
Nov 2, 2022 GNEA
EXAMINERS AMENDMENT -WRITTEN
Nov 2, 2022 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 31, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 31, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 31, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 29, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 17, 2021 NWOS
NEW APPLICATION ENTERED
Jul 15, 2021 NWAP